Nevertheless, it seems that while overexpression of CBS is a feature that characterizes the cancer cells [66,69,70], it is a good prognosis that we observe the lowering of its expression upon S-allyl-L-cysteine exposure, and it may suggest beneficial SAC involvement against the triple-negative breast cancer cells. The gene discussed is CBS; the disease is cancer.